Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F-12 mixture and fetal bovine serum (FBS) were from Iwaki (Tokyo, Japan). Cholera toxin, insulin, gentamicin, RNA extraction buffer (TRIzol), oligo dT primer, and RNase H− reverse transcriptase (SuperScript II) were from Invitrogen (Groningen, The Netherlands). Human epidermal growth factor (EGF) was obtained from BD Biosciences (Bedford, MA), recombinant human TNFα and an immunoassay system (An’Alyza) from Genzyme Techne (Minneapolis, MN), recombinant RNasin RNase inhibitor from Promega (Madison, WI), and NaOCl from Wako (Tokyo, Japan). Alkaline phosphatase (AP) and calpain inhibitor I were purchased from Roche Diagnostics Corp. (Mannheim, Germany), a protein assay kit from Bio-Rad Laboratories (Hercules, CA), and polyvinylidene difluoride membranes from Millipore (Bedford, MA). The affinity-purified rabbit polyclonal antibody for IκBα was from Santa Cruz Biotechnology (Santa Cruz, CA). Donkey anti-rabbit IgG linked to horseradish peroxidase, an enhanced chemiluminescence (ECL) Western blot detection system, and [γ-32P] adenosine triphosphate (ATP) were from Amersham Pharmacia Biotech (Buckinghamshire, UK). T4 oligonucleotide kinase was from Takara Biomedical (Shiga, Japan), and DNA (HotStartTaq) polymerase was from Qiagen (Chatsworth, CA).